This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.
Additional locations may be listed on ClinicalTrials.gov for NCT04169542.
Locations matching your search criteria
United States
Texas
Conroe
MD Anderson in The WoodlandsStatus: Active
Contact: Elizabeth FitzSullivan
Houston
MD Anderson West HoustonStatus: Active
Contact: Carrie K Chu
Phone: 713-794-1247
M D Anderson Cancer CenterStatus: Active
Contact: Carrie K Chu
Phone: 713-794-1247
League City
MD Anderson League CityStatus: Active
Contact: Richard A. Ehlers
Sugar Land
MD Anderson in Sugar LandStatus: Active
Contact: Makesha V. Miggins
PRIMARY OBJECTIVES:
I. Obtain Comprehensive Score for financial Toxicity (COST) questionnaire data from the patients who are undergoing any form of mastectomy (with or without breast reconstruction).
II. To determine which patients are at higher risk of financial toxicity while pursuing breast reconstruction.
III. Assess if financial toxicity or distress is associated with worse BREAST-questionnaire (Q) performance as well as quality of life.
IV. Identify relationships between coronavirus disease 2019 (COVID-19) related productivity losses and financial toxicity.
OUTLINE:
Patients complete up to 4 electronic questionnaires over 15 minutes before surgery and at 6, 12, and 24 months after surgery.
After completion of study, patients will be followed up for 1 year.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationM D Anderson Cancer Center
Principal InvestigatorCarrie K Chu